CHAD Therapeutics has been a pioneer in the field of oxygen conservation since the introduction of the first conserving device in 1983. As the only manufacturer that specializes exclusively in the development of oxygen conserving products, CHAD has been able to establish and maintain a leadership position by staying at the forefront of technological advance.

CHAD was acquired by Inovo, Inc., another leading manufacturer of oxygen regulating and conserving devices, in February of 2008. CHAD's customer service, sales, marketing and production functions are now located at Inovo's headquarters in Naples, Florida.

The combination of Inovo's manufacturing expertise and CHAD's leadership position will allow CHAD to continue in the tradition of innovation and excellence.